Literature DB >> 107186

Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients.

T W Seale, H Thirkill, M Tarpay, M Flux, O M Rennert.   

Abstract

A phenotypic characterization of Pseudomonas aeruginosa from single sputum samples of 21 typical cystic fibrosis patients indicated a high frequency of heterogeneity among isolates on the basis of differences in antibiotic resistance, colony morphology, pigmentation, and serotype. Two or more isolates with different but stable susceptibilities to carbenicillin, gentamycin, streptomycin, tetracycline, chloramphenicol, and sulfamethoxazole plus trimethoprim were detected in 38% of the sputa. Differences generally were independent of the mucoid state of the strain. O-antigen group determination with the Difco typing set showed that two or more serologically distinct strains were present in 10/21 sputum specimens. Nonmucoid derivatives of mucoid isolates almost always retained both the antibiotic susceptibilities and serotype of their parent strain. These data suggest that cystic fibrosis patients may be cocolonized/coinfected by different strains of P. aeruginosa more frequently than generally believed. Alternatively, phenotypically distinct strains from a single patient might arise as phenotypic dissociants from a single infecting strain. Because of the frequency and multiplicity of phenotypically distinct P. aeruginosa isolates which we obtained from our cystic fibrosis patients, it is important to select multiple isolates from sputum cultures for antimicrobial susceptibility testing so as to assess adequately the susceptibility of this organism to antibiotic therapy in cystic fibrosis. We recommend that several colonies of each distinguishable colony type of P. aeruginosa be pooled for the antibiogram.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 107186      PMCID: PMC272959          DOI: 10.1128/jcm.9.1.72-78.1979

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

Review 1.  Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey.

Authors:  N Hoiby
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1977

2.  Pyocine typing of mucoid strains of Pseudomonas aeruginosa isolated from children with cystic fibrosis.

Authors:  R J Williams; J R Govan
Journal:  J Med Microbiol       Date:  1973-08       Impact factor: 2.472

Review 3.  Research in cystic fibrosis (second of three parts).

Authors:  P A di Sant'Agnese; P B Davis
Journal:  N Engl J Med       Date:  1976-09-02       Impact factor: 91.245

4.  Selective inhibition of phagocytic activity of rabbit alveolar macrophages by cystic fibrosis serum.

Authors:  B Boxerbaum; A Kagumba; L W Matthews
Journal:  Am Rev Respir Dis       Date:  1973-10

5.  Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.

Authors:  N Hoiby
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-08

6.  Fine-particle humidifiers. Source of Pseudomonas aeruginosa infections in a respiratory-disease unit.

Authors:  H G Grieble; F R Colton; T J Bird; A Toigo; L G Griffith
Journal:  N Engl J Med       Date:  1970-03-05       Impact factor: 91.245

7.  Epidemiological markers for Pseudomonas aeruginosa. 6. Relationship between concomitant non-mucoid and mucoid strains from the respiratory tract in cystic fibrosis.

Authors:  T Bergan; N Hoiby
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1975-12

8.  Serotyping of Pseudomonas aeruginosa isolates from patients with cystic fibrosis of the pancreas.

Authors:  C H Zierdt; R L Williams
Journal:  J Clin Microbiol       Date:  1975-06       Impact factor: 5.948

9.  Dissociation in Pseudomonas aeruginosa.

Authors:  C H Zierdt; P J Schmidt
Journal:  J Bacteriol       Date:  1964-05       Impact factor: 3.490

10.  Cystic fibrosis: a new outlook. 70 patients above 25 years of age.

Authors:  H Shwachman; M Kowalski; K T Khaw
Journal:  Medicine (Baltimore)       Date:  1977-03       Impact factor: 1.889

View more
  24 in total

1.  Antibiograms, serotypes, and plasmid profiles of Pseudomonas aeruginosa associated with corneal ulcers and contact lens wear.

Authors:  M S Mayo; W L Cook; R L Schlitzer; M A Ward; L A Wilson; D G Ahearn
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

2.  Repeat antimicrobial susceptibility testing of identical isolates.

Authors:  R B Thomson; T M File; R A Burgoon
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

3.  Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  J Cyst Fibros       Date:  2019-04-26       Impact factor: 5.482

Review 4.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

5.  Recovery of Pseudomonas aeruginosa colonial dissociants on a protease detection medium.

Authors:  J M Janda; D J Sheehan; E J Bottone
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

Review 6.  Rational parameters for antibiotic therapy in patients with cystic fibrosis.

Authors:  J R Govan; C Doherty; S Glass
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

7.  Pseudomonas aeruginosa cystic fibrosis isolates from individual patients demonstrate a range of levels of lethality in two Drosophila melanogaster infection models.

Authors:  Erika I Lutter; Monica M P Faria; Harvey R Rabin; Douglas G Storey
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

8.  Cross-sectional and longitudinal multilocus sequence typing of pseudomonas aeruginosa in cystic fibrosis sputum samples.

Authors:  David J Waine; David Honeybourne; E Grace Smith; Joanna L Whitehouse; Chris G Dowson
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

9.  Pseudomonas aeruginosa syntrophy in chronically colonized airways of cystic fibrosis patients.

Authors:  Xuan Qin; Danielle M Zerr; Michael A McNutt; Jessica E Berry; Jane L Burns; Raj P Kapur
Journal:  Antimicrob Agents Chemother       Date:  2012-09-10       Impact factor: 5.191

10.  Influence of culture conditions on expression of the mucoid mode of growth of Pseudomonas aeruginosa.

Authors:  R Chan; J S Lam; K Lam; J W Costerton
Journal:  J Clin Microbiol       Date:  1984-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.